Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
Rapid Micro Biosystems reported an 11.1% increase in total revenue for Q1 2026 to $8.0 million, driven by a 36% rise in product revenue and nearly 30% growth in recurring revenue. The company placed six systems during the quarter and advanced its collaboration with MilliporeSigma. Despite revenue growth, net loss increased to $14.3 million from $11…